RCHY1 and Alzheimer disease: Primarily, we targeted to estimate the alteration in the level of Pirh2 during the experimental model of AD and assessed its particular effect on AD-specific disease markers employing neuronal cells and experimental sporadic rodent model, as approximately ninety percent of cases are of sporadic type [65].